Sanofi-Aventis Deutschland to acquire diabel (insulin) manufacturing plant from Pfizer - MarketLine Financial Deals

Sanofi-Aventis Deutschland to acquire diabel (insulin) manufacturing plant from Pfizer

Sanofi-Aventis Deutschland to acquire diabel (insulin) manufacturing plant from Pfizer - MarketLine Financial Deals
Sanofi-Aventis Deutschland to acquire diabel (insulin) manufacturing plant from Pfizer
Published Jun 08, 2009
2 pages — Published Jun 08, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Sanofi-Aventis Deutschland GmbH has exercised its right to acquire the diabel (insulin) manufacturing plant in Frankfurt-Hochst, Germany, from Pfizer, Inc.

  
Source:
Document ID
MA05192_090612
Country
Country
Country
Ticker
PFE=US
Ticker
SAN=FR
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Sanofi-Aventis Deutschland to acquire diabel (insulin) manufacturing plant from Pfizer" Jun 08, 2009. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sanofi-Aventis-Deutschland-to-acquire-diabel-insulin-manufacturing-plant-from-Pfizer-2052-4970>
  
APA:
MarketLine Financial Deals. (2009). Sanofi-Aventis Deutschland to acquire diabel (insulin) manufacturing plant from Pfizer Jun 08, 2009. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sanofi-Aventis-Deutschland-to-acquire-diabel-insulin-manufacturing-plant-from-Pfizer-2052-4970>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.